Viatris (VTRS) Current Assets (2019 - 2026)
Viatris' (VTRS) quarterly Current Assets came in at $10.9 billion in Q1 2026, up 13.45% year-on-year from $9.6 billion in Q1 2025, and up 11.52% quarter-over-quarter from $9.8 billion in Q4 2025.
Viatris (VTRS) Current Assets (2019 - 2026) Analysis & Trends
Viatris' Current Assets history runs 8 years deep, the most recent figure standing at $10.9 billion for Q1 2026.
- On a quarterly basis, Current Assets rose 13.45% year-over-year to $10.9 billion in Q1 2026; TTM through Mar 2026 was $10.9 billion, a 13.45% increase from a year earlier, with the FY2025 full-year figure at $9.8 billion, up 2.82% from the prior year.
- Current Assets improved to $10.9 billion in Q1 2026 per VTRS's latest filing, from $9.8 billion in the prior quarter.
- Across five years, Current Assets topped out at $13.0 billion in Q4 2023 and bottomed at $9.5 billion in Q4 2024.
- The 5-year median for Current Assets is $10.6 billion (2022), against an average of $10.8 billion.
- Biggest YoY gain for Current Assets was 34.2% in 2024; the steepest drop was 26.63% in 2024.
- Year by year, Current Assets stood at $10.6 billion in 2022, then rose by 22.01% to $13.0 billion in 2023, then fell by 26.63% to $9.5 billion in 2024, then climbed by 2.82% to $9.8 billion in 2025, then advanced by 11.52% to $10.9 billion in 2026.
- Per Business Quant, the three latest VTRS Current Assets figures stand at $10.9 billion (Q1 2026), $9.8 billion (Q4 2025), and $10.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 2.87 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 6.53 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 258.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.92 Bn |
| Dec 31, 2025 | 9.79 Bn |
| Sep 30, 2025 | 9.95 Bn |
| Jun 30, 2025 | 9.77 Bn |
| Mar 31, 2025 | 9.62 Bn |
| Dec 31, 2024 | 9.52 Bn |
| Sep 30, 2024 | 11.31 Bn |
| Jun 30, 2024 | 11.79 Bn |
| Mar 31, 2024 | 12.92 Bn |
| Dec 31, 2023 | 12.98 Bn |
| Sep 30, 2023 | 10.93 Bn |
| Jun 30, 2023 | 9.78 Bn |
| Mar 31, 2023 | 9.63 Bn |
| Dec 31, 2022 | 10.64 Bn |
| Sep 30, 2022 | 10.49 Bn |
| Jun 30, 2022 | 11.18 Bn |
| Mar 31, 2022 | 11.74 Bn |
| Dec 31, 2021 | 10.90 Bn |
| Sep 30, 2021 | 11.31 Bn |
| Jun 30, 2021 | 11.75 Bn |